Antibiotic therapy affects functional behaviour in cystic fibrosis blood mononuclear cells Source: Eur Respir J 2015; 46: 558-561 Year: 2015
Treatment of moderate-severe asthma with omalizumab is associated with a decrease in peripheral blood eosinophils Source: Eur Respir J 2007; 30: Suppl. 51, 353s Year: 2007
Increased priming of blood neutrophils in children with clinically stable cystic fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 341s Year: 2002
Decreased mitochondrial complex I activity in blood lymphocytes of patients with idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020
Successful treatment of lung inflammation is associated with elevation of lymphocyte sensitivity to glucocorticoids Source: Eur Respir J 2001; 18: Suppl. 33, 433s Year: 2001
Longitudinal variability of pulmonary function and sputum eosinophilia in severe refractory asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 479s Year: 2003
RhDNase after airway clearance therapy improves peripheral airway patency in children with cystic fibrosis Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs Year: 2006
Effect of corticosteroids on lymphocytes from severe asthma patients Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012
In vitro responses of peripheral blood mononuclear cells in severe asthma patient treated with Mepolizumab Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020
The involvement of peripheral airways in severe asthma Source: Eur Respir J 2007; 30: Suppl. 51, 600s Year: 2007
Clinical analysis of acute exacerbation of COPD cases with increased eosinophilic granulocytes in peripheral blood Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019
The effect of inhaled steroids on bronchial hyperreactivity, oxidative status, clinical and inflammatory paramerters in patients with cystic fibrosis Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects Year: 2007
Formoterol enhances anti-inflammatory effects of corticosteroid in peripheral blood mononuclear cells from COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 215s Year: 2006
Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment Source: Eur Respir J 2006; 27: 964-971 Year: 2006
Impact of long-term oxygen therapy on systemic inflammation, morphological changes of red blood cells, pulmonary hemodynamics and diaphragm function in patients with chronic obstructive pulmonary disease. Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD Year: 2018
Increased propensity for apoptosis and decreased Bcl-2 in peripheral blood T-cells from COPD patients - effect of corticosteroids? Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004
Systemic inflammation, blood eosinophils count and lung function in COPD patients Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017
Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension Source: Eur Respir J, 55 (6) 2000041; 10.1183/13993003.00041-2020 Year: 2020
Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020
Analysis of peripheral blood lymphocytes in asthma and chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2010 - Lung cell biology and immunology Year: 2010